The Trump administration has recently shown support for medication-assisted treatment and the use of fentanyl test strips. This is a notable acknowledgment given the ongoing opioid crisis.
However, these supportive gestures seem to clash with the administration's recent decisions to impose new limits on funding and policy related to drug treatment.
Such contradictions may create confusion about the administration's true commitment to addressing the drug crisis effectively.